Gastrointestinal cancers

May 1, 2024
Woman patient speaking with doctor
May 1, 2024
Categories

NCCN Recommends Universal Testing for Microsatellite Instability by PCR/NGS or Mismatch Repair by IHC for All Newly Diagnosed Gastric Cancer Patients

EA2212 is a randomized phase 2 study assessing if chemotherapy plus immunotherapy is superior to immunotherapy alone for patients with operable MSI-H/dMMR gastric and/or gastroesophageal junction cancer
Do you like it?
0 Read more
December 19, 2023
December 19, 2023
Categories

Now Enrolling: EA2222/PUMP for Patients With Colorectal Cancer That Has Spread to the Liver

This randomized phase 3 trial is testing whether second-line treatment with hepatic arterial infusion and systemic chemotherapy is more effective than systemic chemotherapy alone
Do you like it?
0 Read more
October 19, 2023
Woman patient speaking with doctor
October 19, 2023
Categories

Now Enrolling: EA2212 for Patients With Gastric and/or Gastroesophageal Junction Cancer

This randomized phase 2 study is assessing if chemotherapy plus immunotherapy is superior to immunotherapy alone for patients with operable MSI-H/dMMR gastric and/or gastroesophageal junction cancer
Do you like it?
0 Read more
August 25, 2023
August 25, 2023
Categories

Trial Spotlight: Efrat Dotan Gives an Update on the EA2186/GIANT Study for Older Adults with Pancreatic Cancer

The GIANT trial (EA2186) is the first randomized clinical trial to focus on vulnerable older adults with treatment-naïve metastatic pancreatic cancer who are not candidates for standard therapy.
Do you like it?
0 Read more
1234